Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2003 1
2004 2
2005 1
2006 5
2007 6
2008 6
2009 3
2010 5
2011 10
2012 5
2013 2
2014 2
2015 2
2016 4
2017 3
2018 1
2019 2
2020 2
2021 1
2023 4
2024 5
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
Ray-Coquard I, Pautier P, Pignata S, Pérol D, González-Martín A, Berger R, Fujiwara K, Vergote I, Colombo N, Mäenpää J, Selle F, Sehouli J, Lorusso D, Guerra Alía EM, Reinthaller A, Nagao S, Lefeuvre-Plesse C, Canzler U, Scambia G, Lortholary A, Marmé F, Combe P, de Gregorio N, Rodrigues M, Buderath P, Dubot C, Burges A, You B, Pujade-Lauraine E, Harter P; PAOLA-1 Investigators. Ray-Coquard I, et al. N Engl J Med. 2019 Dec 19;381(25):2416-2428. doi: 10.1056/NEJMoa1911361. N Engl J Med. 2019. PMID: 31851799 Clinical Trial.
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.
Oaknin A, Gladieff L, Martínez-García J, Villacampa G, Takekuma M, De Giorgi U, Lindemann K, Woelber L, Colombo N, Duska L, Leary A, Godoy-Ortiz A, Nishio S, Angelergues A, Rubio MJ, Fariñas-Madrid L, Yamaguchi S, Lorusso D, Ray-Coquard I, Manso L, Joly F, Alarcón J, Follana P, Romero I, Lebreton C, Pérez-Fidalgo JA, Yunokawa M, Dahlstrand H, D'Hondt V, Randall LM; ENGOT-Cx10–GEICO 68-C–JGOG1084–GOG-3030 Investigators. Oaknin A, et al. Lancet. 2024 Jan 6;403(10421):31-43. doi: 10.1016/S0140-6736(23)02405-4. Epub 2023 Dec 1. Lancet. 2024. PMID: 38048793 Clinical Trial.
Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer.
Leman R, Muller E, Legros A, Goardon N, Chentli I, Atkinson A, Tranchant A, Castera L, Krieger S, Ricou A, Boulouard F, Joly F, Boucly R, Dumont A, Basset N, Coulet F, Chevalier LM, Rouleau E, Leitner K, González-Martin A, Gargiulo P, Lück HJ, Genestie C; PAOLA-1 investigators; Ray-Coquard I, Pujade-Lauraine E, Vaur D. Leman R, et al. Clin Cancer Res. 2023 Nov 1;29(21):4419-4429. doi: 10.1158/1078-0432.CCR-23-0898. Clin Cancer Res. 2023. PMID: 37756555 Free PMC article.
Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Neoadjuvant Chemotherapy Prior to Definitive Radiochemotherapy in Patients with Locally Advanced Cervical Cancer.
Tempfer C, Fehm T, Vordermark D, Marnitz-Schulze S, Beckmann MW, Denschlag D, Brucker S, Wallwiener M, Eichbaum M, Ataseven B, Hillemanns P; für die Kommission Uterus der AGO. Tempfer C, et al. Among authors: eichbaum m. Geburtshilfe Frauenheilkd. 2024 Apr 15;84(6):523-528. doi: 10.1055/a-2279-3163. eCollection 2024 Jun. Geburtshilfe Frauenheilkd. 2024. PMID: 38884027 Free PMC article.
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.
Harter P, Marth C, Mouret-Reynier MA, Cropet C, Lorusso D, Guerra-Alía EM, Matsumoto T, Vergote I, Colombo N, Mäenpää J, Lebreton C, de Gregorio N, Mosconi AM, Rubio-Pérez MJ, Bourgeois H, Fasching PA, Cecere SC, Hardy-Bessard AC, Denschlag D, de Percin S, Hanker L, Favier L, Bauerschlag D, Desauw C, Hillemanns P, Largillier R, Sehouli J, Grenier J, Pujade-Lauraine E, Ray-Coquard I; PAOLA-1/ENGOT-ov25 investigators. Harter P, et al. Ann Oncol. 2024 Nov 9:S0923-7534(24)04907-X. doi: 10.1016/j.annonc.2024.10.828. Online ahead of print. Ann Oncol. 2024. PMID: 39528049 Free article.
[Nuclear medicine procedure guideline for sentinel lymph node localization].
Schmidt M, Hohberg M, Felcht M, Kühn T, Eichbaum M, Krause BJ, Zöphel BK, Kotzerke J; Deutsche Dermatologische Gesellschaft (DDG), vertreten durch; Prof. Dr. M. Felcht (Klinik für Dermatologie, Venerologie und Allergologie, Universitätsmedizin Mannheim); Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG), vertreten durch; Prof. Dr. T. Kühn (Klinik für Frauenheilkunde und Geburtshilfe, Klinikum Esslingen) und; Prof. Dr. M. Eichbaum (Klinik für Gynäkologie und gynäkologische Onkologie, Helios Dr.-Horst-Schmidt-Kliniken Wiesbaden). Schmidt M, et al. Among authors: eichbaum m. Nuklearmedizin. 2024 Aug;63(4):233-246. doi: 10.1055/a-2319-8306. Epub 2024 May 24. Nuklearmedizin. 2024. PMID: 38788776 Free article. German.
Giant struma ovarii.
Friedrich OL, Sinn HP, Sohn C, Eichbaum M. Friedrich OL, et al. Among authors: eichbaum m. Arch Gynecol Obstet. 2013 Feb;287(2):399-400. doi: 10.1007/s00404-012-2533-x. Epub 2012 Aug 28. Arch Gynecol Obstet. 2013. PMID: 22926802 No abstract available.
Laparoscopic Treatment of an Interstitial Ectopic Pregnancy.
Eichbaum M, Asrar H, Klee A, Eichbaum C. Eichbaum M, et al. J Minim Invasive Gynecol. 2021 Jun;28(6):1135-1136. doi: 10.1016/j.jmig.2020.12.010. Epub 2020 Dec 31. J Minim Invasive Gynecol. 2021. PMID: 33333237 No abstract available.
67 results